Actual Medicinal Product (AMP) - Omjjara 100mg tablets (GlaxoSmithKline UK Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Omjjara 100mg tablets | Start Date 19-02-2024 | End Date |
Summary
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
| Code | Start Date | End Date |
|---|---|---|
| 42643611000001104 | 19-02-2024 |
Parent Products
-
VTMMomelotinib
-
VMPMomelotinib 100mg tablets
-
AMP(Current) Omjjara 100mg tablets (GlaxoSm...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 30 tablet | 565000 |